STOCK TITAN

Haemonetics officer proposes $101K share sale

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Haemonetics Corp officer Maryanne Farris reported a proposed sale of 836 common shares, with an aggregate market value of $101,144.38 and an approximate sale date of November 11, 2026. The securities table lists three restricted-stock vesting acquisitions and one stock option exercise among the acquisition transactions for securities identified for sale.

Shares reported for sale 836 shares Proposed sale of common shares
Aggregate market value $101,144.38 Common shares reported for sale
Shares acquired through restricted stock vesting 137 shares May 15, 2024
Shares acquired through restricted stock vesting 150 shares May 15, 2025
Shares acquired through restricted stock vesting 127 shares May 17, 2025
Shares acquired through stock option exercise 422 shares November 11, 2026
Restricted Stock Vesting financial
"137 shares acquired through Restricted Stock Vesting"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
Stock Option Exercise financial
"422 shares acquired through Stock Option Exercise"
A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.
Aggregate Market Value financial
"Aggregate Market Value of $101,144.38"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many HAE shares did Maryanne Farris report for sale?

Maryanne Farris reported a proposed sale of 836 common shares, with an aggregate market value of $101,144.38 and an approximate sale date of November 11, 2026.

How did Maryanne Farris acquire the HAE shares listed for sale?

The securities table lists 137 shares from restricted stock vesting on May 15, 2024, 150 shares from restricted stock vesting on May 15, 2025, 127 shares from restricted stock vesting on May 17, 2025, and 422 shares from a stock option exercise on November 11, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading